Acute Hepatitis A Virus Infection in Tobruk, Eastern Libya: Increasing Trends After 2017.
Acute hepatitis A virus
Contaminated food and water
HAV outbreak
Libya
Seroprevalence
Journal
Food and environmental virology
ISSN: 1867-0342
Titre abrégé: Food Environ Virol
Pays: United States
ID NLM: 101483831
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
11
05
2021
accepted:
07
10
2021
pubmed:
12
10
2021
medline:
5
3
2022
entrez:
11
10
2021
Statut:
ppublish
Résumé
Acute hepatitis A is a self-limited liver inflammation caused by hepatitis A virus (HAV) infection. The infection is transmitted by direct contact from person to person via fecal-oral routes, or through consuming contaminated food and water. This study aims to estimate the frequency of HAV infection from medical records of Tobruk Medical Center, eastern Libya and its distribution during 6 years. The medical records department of Tobruk Medical Center follows guidelines of the international classification of diseases-10 for coding the diseases. The research estimates the frequency and distribution of HAV infection based on age and sex during the period from January 2015 to December 2020. HAV screening assay was performed using commercially available enzyme-linked immunosorbent assays HAV IgM microwell. 245 cases were recorded, 53.5% of cases were males. HAV infection was the most prevalent (92.6%) in age groups of < 5-20 years. A significant rise in the occurrence of HAV infection in the last three years was reported (p < 0.05). More than half of the cases (68%) were reported in 2019 and 2020. No case fatality rate was reported in the present study. There is an increase in the frequency of HAV infection in the last 3 years and the younger age groups (under 20 years old) are more vulnerable to HAV infection. More prevention and control efforts towards this age group should be a top public health priority to avoid the possibility of HAV outbreaks in the future.
Identifiants
pubmed: 34633604
doi: 10.1007/s12560-021-09499-5
pii: 10.1007/s12560-021-09499-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
89-93Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Abutaleb, A., & Kottilil, S. (2020). Hepatitis A: Epidemiology, natural history, unusual clinical manifestations, and prevention. Gastroenterology Clinics of North America, 49(2), 191–199. https://doi.org/10.1016/j.gtc.2020.01.002
doi: 10.1016/j.gtc.2020.01.002
pubmed: 32389358
pmcid: 7883407
Barzaga, B. N. (2000). Hepatitis A shifting epidemiology in south-east asia and china. Vaccine, 18(Suppl 1), S61-64. https://doi.org/10.1016/s0264-410x(99)00467-3
doi: 10.1016/s0264-410x(99)00467-3
pubmed: 10683551
Bureau of Statistics and Census, Libya. (2020). Estimation of libyan population according to regions, from http://bsc.ly/?P=5&sec_Id=8&dep_Id=7#144 Accessed 06 Aug 2021.
Cao, J., Wang, Y., Song, H., Meng, Q., Sheng, L., Bian, T., Mahemuti, W., Yierhali, A., Omata, M., & Bi, S. (2009). Hepatitis A outbreaks in china during 2006: Application of molecular epidemiology. Hepatology International, 3(2), 356–363. https://doi.org/10.1007/s12072-008-9116-8
doi: 10.1007/s12072-008-9116-8
pubmed: 19669361
Committee on Infectious Diseases. (2007). Hepatitis A vaccine recommendations. Pediatrics, 120(1), 189. https://doi.org/10.1542/peds.2007-1088
doi: 10.1542/peds.2007-1088
Cuthbert, J. A. (2001). Hepatitis A: Old and new. Clinical Microbiology Reviews, 14(1), 38–58. https://doi.org/10.1128/cmr.14.1.38-58.2001
doi: 10.1128/cmr.14.1.38-58.2001
pubmed: 11148002
pmcid: 88961
Daw, M. A., El-Bouzedi, A., & Dau, A. A. (2015). Libyan armed conflict 2011: Mortality, injury and population displacement. African Journal of Emergency Medicine, 5(3), 101–107. https://doi.org/10.1016/j.afjem.2015.02.002
doi: 10.1016/j.afjem.2015.02.002
Fares, A. (2015). Seasonality of hepatitis: A review update. Journal of Family Medicine and Primary Care, 4(1), 96–100. https://doi.org/10.4103/2249-4863.152263
doi: 10.4103/2249-4863.152263
pubmed: 25810997
pmcid: 4367015
Fiore, A. E. (2004). Hepatitis A transmitted by food. Clinical Infectious Diseases, 38(5), 705–715. https://doi.org/10.1086/381671
doi: 10.1086/381671
pubmed: 14986256
Fouad, H. M., Reyad, E. M., & El-Din, A. G. (2018). Acute hepatitis A is the chief etiology of acute hepatitis in egyptian children: A single-center study. European Journal of Clinical Microbiology & Infectious Diseases, 37(10), 1941–1947. https://doi.org/10.1007/s10096-018-3329-0
doi: 10.1007/s10096-018-3329-0
Gardner, P., Eickhoff, T., Poland, G. A., Gross, P., Griffin, M., LaForce, F. M., Schaffner, W., & Strikas, R. (1996). Adult immunizations. Annals of Internal Medicine, 124(1 Pt 1), 35–40. https://doi.org/10.7326/0003-4819-124-1_part_1-199601010-00007
doi: 10.7326/0003-4819-124-1_part_1-199601010-00007
pubmed: 7503476
Hadler, S. C., Webster, H. M., Erben, J. J., Swanson, J. E., & Maynard, J. E. (1980). Hepatitis A in day-care centers. A community-wide assessment. The New England Journal of Medicine, 302(22), 1222–1227. https://doi.org/10.1056/nejm198005293022203
doi: 10.1056/nejm198005293022203
pubmed: 6245363
Innis, B. L., Snitbhan, R., Kunasol, P., Laorakpongse, T., Poopatanakool, W., Kozik, C. A., Suntayakorn, S., Suknuntapong, T., Safary, A., Tang, D. B., et al. (1994). Protection against hepatitis A by an inactivated vaccine. JAMA, 271(17), 1328–1334.
doi: 10.1001/jama.1994.03510410040030
Jacobsen, K. H., & Wiersma, S. T. (2010). Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine, 28(41), 6653–6657. https://doi.org/10.1016/j.vaccine.2010.08.037
doi: 10.1016/j.vaccine.2010.08.037
pubmed: 20723630
Karagöz, G., Ak, O., & Ozer, S. (2005). The coexistence of hepatitis A and infectious mononucleosis. The Turkish Journal of Gastroenterology, 16(2), 102–104.
pubmed: 16252202
Kim, Y. J., & Lee, H. S. (2010). Increasing incidence of hepatitis A in korean adults. Intervirology, 53(1), 10–14. https://doi.org/10.1159/000252778
doi: 10.1159/000252778
pubmed: 20068335
Koff, R. S. (1998). Hepatitis A. Lancet, 351(9116), 1643–1649. https://doi.org/10.1016/s0140-6736(98)01304-x
doi: 10.1016/s0140-6736(98)01304-x
pubmed: 9620732
Kunasol, P., Cooksley, G., Chan, V. F., Isahak, I., John, J., Loleka, S., Villar, E. P., Poovorawan, Y., Seong, N. H., Sulaiman, H. A., & Wah, L. B. (1998). Hepatitis A virus: Declining seroprevalence in children and adolescents in southeast asia. Southeast Asian Journal of Tropical Medicine and Public Health, 29(2), 255–262.
Lednar, W. M., Lemon, S. M., Kirkpatrick, J. W., Redfield, R. R., Fields, M. L., & Kelley, P. W. (1985). Frequency of illness associated with epidemic hepatitis A virus infections in adults. American Journal of Epidemiology, 122(2), 226–233. https://doi.org/10.1093/oxfordjournals.aje.a114093
doi: 10.1093/oxfordjournals.aje.a114093
pubmed: 3860002
Lemon, S. M. (1994). The natural history of hepatitis A: The potential for transmission by transfusion of blood or blood products. Vox Sang, 67(4), 19–23; discussion 24–16.
Mannucci, P. M., Gdovin, S., Gringeri, A., Colombo, M., Mele, A., Schinaia, N., Ciavarella, N., Emerson, S. U., & Purcell, R. H. (1994). Transmission of hepatitis A to patients with hemophilia by factor viii concentrates treated with organic solvent and detergent to inactivate viruses: The italian collaborative group. Annals of Internal Medicine, 120(1), 1–7. https://doi.org/10.7326/0003-4819-120-1-199401010-00001
doi: 10.7326/0003-4819-120-1-199401010-00001
pubmed: 7504424
Roos, B. (1956). hepatitis epidemic transmitted by oysters. Sven Lakartidn, 53(16), 989–1003.
pubmed: 13324708
Sacher, R. A., Peters, S. M., & Bryan, J. A. (2000). Testing for viral hepatitis: A practice parameter. American Journal of Clinical Pathology, 113(1), 12–17. https://doi.org/10.1309/xhbk-c91t-y2c6-6l0b
doi: 10.1309/xhbk-c91t-y2c6-6l0b
pubmed: 10631853
Sattar, S. A., Jason, T., Bidawid, S., & Farber, J. (2000). Foodborne spread of hepatitis A: Recent studies on virus survival, transfer and inactivation. Canadian Journal of Infectious Diseases, 11(3), 159–163. https://doi.org/10.1155/2000/805156
doi: 10.1155/2000/805156
Sebastian, B., Mathai, S., Mathew, G., Ouseph, M., & Balakrishnan, P. (2001). An outbreak of hepatitis A in central india: Changing patterns. Indian Journal of Gastroenterology, 20, 132–135.
Singh, J., Prakash, C., Gupta, R. S., Bora, D., Jain, D. C., & Datta, K. K. (1997). Epidemiology of endemic viral hepatitis in an urban area of india: A retrospective community study in alwar. Bulletin of the World Health Organization, 75(5), 463–468.
pubmed: 9447780
pmcid: 2487007
Soucie, J. M., Robertson, B. H., Bell, B. P., McCaustland, K. A., & Evatt, B. L. (1998). Hepatitis A virus infections associated with clotting factor concentrate in the united states. Transfusion, 38(6), 573–579. https://doi.org/10.1046/j.1537-2995.1998.38698326337.x
doi: 10.1046/j.1537-2995.1998.38698326337.x
pubmed: 9661691
Steffen, R. (2005). Changing travel-related global epidemiology of hepatitis A. American Journal of Medicine, 118(Suppl 10A), 46s–49s. https://doi.org/10.1016/j.amjmed.2005.07.016
doi: 10.1016/j.amjmed.2005.07.016
Trujillo-Ochoa, J. L., Viera-Segura, O., & Fierro, N. A. (2019). Challenges in management of hepatitis A virus epidemiological transition in mexico. Annals of Hepatology, 18(1), 14–22. https://doi.org/10.5604/01.3001.0012.7857
doi: 10.5604/01.3001.0012.7857
pubmed: 31113583
Villar, L. M., De Paula, V. S., & Gaspar, A. M. (2002). Seasonal variation of hepatitis A virus infection in the city of rio de janeiro, Brazil. Revista Do Instituto De Medicina Tropical De Sao Paulo, 44(5), 289–292. https://doi.org/10.1590/s0036-46652002000500011
doi: 10.1590/s0036-46652002000500011
pubmed: 12436171
Wasley, A., Fiore, A., & Bell, B. P. (2006). Hepatitis A in the era of vaccination. Epidemiologic Reviews, 28, 101–111. https://doi.org/10.1093/epirev/mxj012
doi: 10.1093/epirev/mxj012
pubmed: 16775039
WHO. (2020). Hepatitis A fact sheet, from https://www.who.int/news-room/fact-sheets/detail/hepatitis-a Accessed 08 March 2020.
Who position paper on hepatitis A vaccines: June 2012—recommendations. (2013). Vaccine, 31(2), 285–286. https://doi.org/10.1016/j.vaccine.2012.10.102
Yamamoto, C., Ko, K., Nagashima, S., Harakawa, T., Fujii, T., Ohisa, M., Katayama, K., Takahashi, K., & Okamoto, H. (2019). Very low prevalence of anti-hav in japan: High potential for future outbreak. Scientific Reports, 9(1), 1493. https://doi.org/10.1038/s41598-018-37349-1
doi: 10.1038/s41598-018-37349-1
pubmed: 30728377
pmcid: 6365493